| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Results in Impairment of Wound Healing and Enhancement of Tumor Formation in Mouse Skin Carcinogenesis1
Department of Animal Resource Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan [K. C., T. Ha., T. Hi.]; Department of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan [C. K.]; Mitsubishi Kagaku Institute of Life Sciences, Tokyo 194-8511, Japan [K. Nakam.]; RIKEN Center for Developmental Biology, Hyogo 650-0047, Japan [K. Nakao]; Department of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Hyogo 650-0017, Japan [A. A.]; National Institute of Basic Biology, Aichi 444-8585, Japan [M. K.]; and Gifu University, Gifu 501-1193, Japan [T. K.]
We have generated a mouse strain lacking protein kinase C (PKC)
to evaluate its significance in epithelial organization and tumor formation. The PKC
-deficient mice exhibited increased susceptibility to tumor formation in two-stage skin carcinogenesis by single application of 7,12-dimethylbenz(a)anthracene (DMBA) for tumor initiation and repeated applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) for tumor promotion. The tumor formation was not enhanced by DMBA or TPA treatment alone, suggesting that PKC
suppresses tumor promotion. Epidermal hyperplasia induced by topical TPA treatment was prolonged in the mutant mice. The enhanced tumor formation may be closely associated with the prolonged hyperplasia induced by topical TPA treatment. In the mutant mice, after inflicting injury by punch biopsy, wound healing on the dorsal skin, particularly reepithelialization, was significantly delayed and impaired in structure. Impairment of epithelial regeneration in wound healing indicates a possibility that PKC
plays a role in maintenance of epithelial architecture. Homeostasis in epithelial tissues mediated by PKC
is important for tumor formation in vivo. We propose that PKC
is involved in tumor formation modulated by regulation of proliferation and remodeling of epithelial cells in vivo.
This article has been cited by other articles:
![]() |
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester Cancer Res., January 1, 2008; 68(1): 64 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oster and M. Leitges Protein Kinase C {alpha} but not PKC{zeta} Suppresses Intestinal Tumor Formation in ApcMin/+ Mice. Cancer Res., July 15, 2006; 66(14): 6955 - 6963. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis Cancer Res., August 15, 2005; 65(16): 7356 - 7362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. D. Anel and V. Malhotra PKC{eta} is required for {beta}1{gamma}2/{beta}3{gamma}2- and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus J. Cell Biol., April 11, 2005; 169(1): 83 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Reichenberger, R. D. Coletta, A. P. Schulte, M. Varella-Garcia, and H. L. Ford Gene Amplification Is a Mechanism of Six1 Overexpression in Breast Cancer Cancer Res., April 1, 2005; 65(7): 2668 - 2675. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bai, H. Edamatsu, S. Maeda, H. Saito, N. Suzuki, T. Satoh, and T. Kataoka Crucial Role of Phospholipase C{epsilon} in Chemical Carcinogen-Induced Skin Tumor Development Cancer Res., December 15, 2004; 64(24): 8808 - 8810. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Wheeler, K. E. Martin, K. J. Ness, Y. Li, N. E. Dreckschmidt, M. Wartman, H. N. Ananthaswamy, D. L. Mitchell, and A. K. Verma Protein Kinase C {epsilon} Is an Endogenous Photosensitizer That Enhances Ultraviolet Radiation-Induced Cutaneous Damage and Development of Squamous Cell Carcinomas1 Cancer Res., November 1, 2004; 64(21): 7756 - 7765. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ogbourne, A. Suhrbier, B. Jones, S.-J. Cozzi, G. M. Boyle, M. Morris, D. McAlpine, J. Johns, T. M. Scott, K. P. Sutherland, et al. Antitumor Activity of 3-Ingenyl Angelate: Plasma Membrane and Mitochondrial Disruption and Necrotic Cell Death Cancer Res., April 15, 2004; 64(8): 2833 - 2839. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |